SXTSENSIENT TECHNOLOGIES CORP
Industrial Organic Chemicals
- Revenue
- $1.6B
- 3.5% YoY
- Operating margin
- 12.8%
- 4.4% YoY
- EBITDA
- $268M
- 6.5% YoY
- Market cap
- $5.0B
- Employees
- 807
- $2M revenue each
- Net debt / EBITDA
- 2.5×
- $667M net debt
- AI in 10-K
- 1.4
- mentions per 10K words
Takeover score 1 of 13
Fixable underperformance 0 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo95% of net incomeCash flow under 80% of net income
- Dilutive SBCNo1% of revenueOver 10% of revenue
- Payouts exceed cash flowNo54% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo18% of assetsOver 40% of assets
- Shareholder dissentNo97% lowest supportAny vote under 80% support
Buyer economics 0 of 4
- Low revenue per employeeNo$2M · 90th pctBottom quartile of its SIC industry
- Quiet on AINo1.4 per 10K words · 43rd pctBottom quartile of AI mentions in 10-Ks
- Net cashNo2.5× EBITDA net debtMore cash than debt, positive EBITDA
- Buyout-sizedNo$5.0B market capMarket cap $500M–$5B
Catalysts 1 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingYes−$234M netNet sales over $10M in 12 months
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $1.4B | $1.5B | $1.6B | $1.6B | 3.5% |
| Operating income | $170M | $197M | $155M | $192M | $207M | 8.1% |
| Net income | $119M | $141M | $93M | $125M | $134M | 7.9% |
| Operating cash flow | $145M | $12M | $170M | $157M | $128M | 19% |
| Capex | $61M | $79M | $88M | $59M | $89M | 51% |
| Stock-based comp | $10M | $16M | $9M | $10M | $14M | 38% |
| Buybacks | $43M | $0 | $0 | — | — | |
| Dividends | $67M | $69M | $69M | $69M | $70M | 0.3% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $291K · 2
- Open-market sells, 12 mo
- $234M · 7
- Net
- −$234M
Pay vs performance
No pay-versus-performance disclosure yet.